The continuous increase in resistance development towards antimicrobial agents is a well-known problem, however, insecurities exist about how frequently the emergence of resistance in microbes, at the same time, leads to an increased sensitivity to other antimicrobial agents. This phenomenon is called “collateral sensitivity”. We evolved resistance in clinical E. coli strains towards three antimicrobial ...